Skip to content
OpenCapital
Get started

Precision BioSciences, Inc. DTIL Q4 2024 Annual earnings

Reported March 26, 2025 · Before market open

Revenue$638.0KMiss by $9.4M
EPS-$3.20Miss by $1.11
Revenue estimate$10.0M
EPS estimate-$2.09

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$1.4M
EPS estimate-$0.71

Versus estimates

Revenue

Q1 2026$10.8MBeat by $6.8MQ4 2025$34.2MBeat by $25.1MQ3 2025$13.0KMiss by $9.1MQ2 2025$18.0KMiss by $5.4MQ1 2025$29.0KMiss by $6.2M
Q4 2024$638.0KMiss by $9.4M

Diluted EPS

Q1 2026-$0.34Miss by $0.07Q4 2025$0.36Beat by $0.57Q3 2025-$1.84Miss by $1.53Q2 2025-$2.13Miss by $2.04Q1 2025-$2.21Miss by $1.78
Q4 2024-$3.20Miss by $1.11

Ask the moment Precision BioSciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Precision BioSciences, Inc. report Q4 2024 earnings?
Precision BioSciences, Inc. (DTIL) reported Q4 2024 earnings on March 26, 2025 before market open.
What were Precision BioSciences, Inc.'s Q4 2024 revenue and EPS?
Precision BioSciences, Inc. reported revenue of $638.0K and eps of $-3.20 for Q4 2024.
Did Precision BioSciences, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $10.0M by $9.4M. EPS missed the consensus estimate of $-2.09 by $1.11.
Where can I find Precision BioSciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-044775) directly on SEC EDGAR. The filing index links above go to sec.gov.